Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection

Arthritis Rheum. 1988 Jun;31(6):789-92. doi: 10.1002/art.1780310615.

Abstract

Because of failure to fully respond to an initial intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates, 17 patients with seropositive rheumatoid arthritis underwent repeat radiation synovectomy using this agent. Of the 13 patients who were evaluated 1 year later, 54% (7 knees) had good results, 31% (4 knees) had fair results, and 15% (2 knees) had poor results. The initial lack of significant benefit from radiation synovectomy did not appear to preclude a favorable response to a second injection.

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / physiopathology
  • Arthritis, Rheumatoid / radiotherapy*
  • Dysprosium / administration & dosage
  • Dysprosium / therapeutic use*
  • Evaluation Studies as Topic
  • Ferric Compounds / administration & dosage
  • Ferric Compounds / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Injections, Intra-Articular
  • Knee Joint*
  • Middle Aged
  • Pain
  • Radioisotopes / administration & dosage
  • Radioisotopes / therapeutic use*
  • Recurrence
  • Synovial Membrane*
  • Veins

Substances

  • Ferric Compounds
  • Radioisotopes
  • Dysprosium
  • ferric hydroxide